Showing 531-540 of 7932 results for "".
Meaningful Innovation in Medical Dermatology at Arcutis Biotherapeutics
https://practicaldermatology.com/topics/psoriasis/meaningful-innovation-in-medical-dermatology-at-arcutis-biotherapeutics/20099/Frank Watanabe, President and CEO of Arcutis Biotherapeutics, shares what “meaningful innovation” means to Arcutis and how the company aims to create meaningful change for people living with chronic skin conditions.Get Ready for JAK Inhibitors
https://practicaldermatology.com/topics/psoriasis/get-ready-for-jak-inhibitors/19928/JAK inhibitors are going to change the way we think about refractory disease, says Brett King, MD. He addresses the significant increase in study of these agents and the many potential uses for refractory diseases like alopecia, atopic dermatitis, vitiligo, psoriasis, and more.Itching for Answers: Understanding and Treating Pruritus
https://practicaldermatology.com/topics/general-topics/itching-for-answers-understanding-and-treating-pruritus/18493/Since childhood, when he was affected by eczema and associated pruritus, Ethan Lerner, MD, PhD has been fascinated by itch, its causes, and its potential treatments. In this edition of Benchside Dispatches, he offers a fresh look at the latest research on pruritus and the challenges facing scientistAD Impact, Allofill Comes to Market, GPA Launches
https://practicaldermatology.com/topics/psoriasis/dermwiretv-ad-impact-allofill-comes-to-market-gpa-launches/18567/From sleep disruptions or negative impact on the ability to work to feelings of depression and anxiety, atopic dermatitis can have significant effects on adults, new research suggests. In fact, more than half of respondents to a Harris Poll say that AD has negatively impacted their daily lives. DoriPatient Outreach Initiatives; Erelzi Approved
https://practicaldermatology.com/topics/practice-management/dermwiretv-patient-outreach-initiatives-erelzi-approved---etudruli/18580/DermatologistOnCall® Partners with NPF to enhance access to care for psoriasis. Vivacare Partners with NRS for patient education. Erelzi from Sandoz approved as biosimilar to Enbrel. And the FDA bans antibacterial ingredients from hand soaps; Calls for plain soap and water hand washing.Incorporating Cosmetic Dermatology into Your Medical Practice
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/incorporating-cosmetic-dermatology-into-your-medical-practice/18763/Cosmetic Dermatology experts Gary D. Monheit, MD, Nancy J. Samolitis, MD, and Joel L. Cohen, MD share tips for adding aesthetic offerings to an established medical dermatology practice or for young physicians opening a new practice. Sitting down with host Neal Bhatia, MD, they all emphasize the impoVehicle Innovations: Experts Discuss What's New
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/vehicle-innovations-experts-discuss-what-s-new/18915/Peter Lio, MD and Elaine Siegfried, MD discuss recent innovations in the science behind new vehicles and how these innovations improve treatment, as well as what may hinder some patients' access to these new vehicles. They also offer tips on treatment action plans for atopic patients.Minimally Invasive Trends
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/minimally-invasive-trends/19055/Michael H. Gold, MD talks about the latest trends in minimally invasive procedures, including for rejuvenation of the neck.Pearls for Managing Rosacea During Home Isolation
https://practicaldermatology.com/topics/acne-rosacea/pearls-for-managing-rosacea-during-home-isolation/23279/Encourage patients to keep up with skincare and prescription regimens and be prepared to offer in-office procedures when appropriate.New in My Practice: Cosmeceutical
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-cosmeceutical/23943/